Research will examine individuals' DNA to determine susceptibility to opioid dependence, responsiveness to opioid and non-opioid therapies
Elysium Heath also announced Morgan Levine, Ph.D., of Yale School of Medicine has joined the company as head of bioinformatics to improve the testing methodology of Index, with the goal of making its application accurate and informative for individuals.
Molecular diagnostics accounts for only a tenth of the in vitro diagnostics (IVD) market—but most of its hopes for future revenue growth.
Sequencing experts fill in gaps, confront genomic diversity, and ponder the complexities posed by multiple reference genomes
Through the acquisition, Invitae will gain access to Clear Genetics' chatbot named Gia, short for “Genetic Information Assistant,” which is designed to offer patients guidance for understanding test results.
The investment builds on a collaboration begun in 2015 to develop T2's diagnostic for Lyme disease that uses its T2MR mini MRI platform.
Companies plan to combine Fabric Genomics’ analysis tools with ITTM’s secure hosting and infrastructure solutions.
Sequencing the RNA of single cells is unlocking the secrets of tumor heterogeneity and opening doors to better cancer diagnostics.
Few gadgets in modern science are more intriguing than a hand-held, USB compatible, real-time DNA sequencer. The possibility of sequencing anyone, anywhere, and anytime...
Genomenon said today it has won a Small Business Innovation Research (SBIR) grant from the NIH’s National Human Genome Research Institute (NHGRI). Funding from the...